| | | | | | | | | | |
|
|
| Dockets Entered
On July 8, 2005
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
|
|
|
|
| 2001N-0548
|
| Guidelines for Voluntary Nutrition Labeling of Raw Fruits
|
|
|
| 2004P-0013
|
| Review safety of Nutropin Depot Injection, issue direction to Genentech Inc. to add warnings regarding diabetes in their safety literature, and consider amending 21 CFR 314.80(e) Postmarketing studies
|
|
|
|
| 2004P-0068
|
| Establish specific bioequivalence requirements for oral products contanining desmopressin
|
|
|
| 2005N-0137
|
| Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
|
|
|
| 2005N-0276
|
| prior notice and recordkeeping requirements (21 CFR Part 1,subpart I and J) to food samples for quality assurance,research, or analysis purposes
|
|
|
| 2005P-0170
|
| ANADA for a generic ivermectin soft chew that differs in dosage form for horses
|
|
|
| 2005P-0277
|
| ANADA Suitability for generic version of EXCENEL RTU, ceftiofur hydrochloride sterile suspension
|
|
|
| 2005P-0278
|
| prior notice of imports (21 CFR part 1,subpart I) and establishment and maintenance of records (21CFR Part 1,subpart J).
|
|
|
| 2001N-0548
|
| Guidelines for Voluntary Nutrition Labeling of Raw Fruits
|
|
|
| EMC
15
|
| Food Research Inc (California Kiwifruit Commission, Chilean Fresh Fruit Association, et al
|
| Vol #:
|
| 5
|
|
|
| EMC
16
|
| University of Hawaii at Manoa
|
| Vol #:
|
| 5
|
|
|
| EMC
17
|
| University of Hawaii at Manoa
|
| Vol #:
|
| 5
|
|
|
| EMC
18
|
| China WTO/TBT National Notification & Enquiry Center
|
| Vol #:
|
| 5
|
|
|
| EMC
19
|
| Produce for Better Health Foundation (PBH)
|
| Vol #:
|
| 5
|
|
|
| EMC
20
|
| U S Apple Association
|
| Vol #:
|
| 5
|
|
|
| EMC
21
|
| California Strawberry Commission (CSC)
|
| Vol #:
|
| 5
|
|
|
| EMC
22
|
| United Fresh Fruit and Vegetable Association
|
| Vol #:
|
| 5
|
|
|
| EMC
23
|
| National Watermelon Promotion Board
|
| Vol #:
|
| 5
|
|
|
| 2004P-0013
|
| Review safety of Nutropin Depot Injection, issue direction to Genentech Inc. to add warnings regarding diabetes in their safety literature, and consider amending 21 CFR 314.80(e) Postmarketing studies
|
|
|
|
|
|
| SUP
1
|
| Consumer
|
| Vol #:
|
| 1
|
|
|
| 2004P-0068
|
| Establish specific bioequivalence requirements for oral products contanining desmopressin
|
|
|
| REF
1
Appendix
1
|
| HFD-1 re: NDA 19-955 (Review of Two Pharmacokinetic Studies in a new NDA)
|
| Vol #:
|
| 1
|
|
|
| 2005N-0137
|
| Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
|
|
|
| EXT
1
|
| Abbott Laboratories
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2005N-0276
|
| prior notice and recordkeeping requirements (21 CFR Part 1,subpart I and J) to food samples for quality assurance,research, or analysis purposes
|
|
|
| CP 1
|
| number not used
|
| Vol #:
|
| 1
|
|
|
| 2005P-0170
|
| ANADA for a generic ivermectin soft chew that differs in dosage form for horses
|
|
|
| PAV
1
|
| HFV-1 to Intervet, Inc
|
| Vol #:
|
| 1
|
|
|
| 2005P-0277
|
| ANADA Suitability for generic version of EXCENEL RTU, ceftiofur hydrochloride sterile suspension
|
|
|
| ACK
1
|
| HFA-305 to Pfizer Animal Health
|
| Vol #:
|
| 1
|
|
|
| CP
1
Attachment
|
| Pfizer Animal Health
|
| Vol #:
|
| 1
|
|
|
| 2005P-0278
|
| prior notice of imports (21 CFR part 1,subpart I) and establishment and maintenance of records (21CFR Part 1,subpart J).
|
|
|
| ACK
1
|
| HFA-305 to National Institute of Oilseed Products
|
| Vol #:
|
| 1
|
|
|
| CP
1
|
| National Institute of Oilseed Products
|
| Vol #:
|
| 1
|
|